118 related articles for article (PubMed ID: 3321938)
1. An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial.
Holmgren J; Svennerholm AM; Clemens J; Sack D; Black R; Levine M
Adv Exp Med Biol; 1987; 216B():1649-60. PubMed ID: 3321938
[No Abstract] [Full Text] [Related]
2. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
3. [Cholera vaccine].
Ehara M
Nihon Rinsho; 2005 May; 63 Suppl 5():625-30. PubMed ID: 15954420
[No Abstract] [Full Text] [Related]
4. Oral immunization against experimental cholera: the role of antigen form and antigen combinations in evoking protection.
Pierce NF; Cray WC; Sacci JB; Craig JP; Germanier R; Fürer E
Ann N Y Acad Sci; 1983 Jun; 409():724-33. PubMed ID: 6603186
[No Abstract] [Full Text] [Related]
5. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1992; 10(2):130-2. PubMed ID: 1539466
[TBL] [Abstract][Full Text] [Related]
7. New cholera vaccines.
Holmgren J; Clemens J; Sack DA; Svennerholm AM
Vaccine; 1989 Apr; 7(2):94-6. PubMed ID: 2665353
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
Black RE; Levine MM; Clements ML; Young CR; Svennerholm AM; Holmgren J
Infect Immun; 1987 May; 55(5):1116-20. PubMed ID: 3552989
[TBL] [Abstract][Full Text] [Related]
9. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
11. CpG DNA, liposome and refined antigen oral cholera vaccine.
Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
[TBL] [Abstract][Full Text] [Related]
12. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children.
Saha A; Chowdhury MI; Nazim M; Alam MM; Ahmed T; Hossain MB; Hore SK; Sultana GN; Svennerholm AM; Qadri F
Vaccine; 2013 Jan; 31(4):647-52. PubMed ID: 23200936
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a live oral cholera vaccine in human volunteers.
Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
[TBL] [Abstract][Full Text] [Related]
14. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.
Svennerholm AM; Holmgren J
Adv Exp Med Biol; 1995; 371B():1623-8. PubMed ID: 7502870
[No Abstract] [Full Text] [Related]
15. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization against cholera.
Holmgren J; Clemens J; Sack DA; Sanchez J; Svennerholm AM
Curr Top Microbiol Immunol; 1989; 146():197-204. PubMed ID: 2659268
[No Abstract] [Full Text] [Related]
17. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
18. Oral cholera vaccines: use in clinical practice.
Hill DR; Ford L; Lalloo DG
Lancet Infect Dis; 2006 Jun; 6(6):361-73. PubMed ID: 16728322
[TBL] [Abstract][Full Text] [Related]
19. Cholera vaccines.
Ryan ET; Calderwood SB
Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
[TBL] [Abstract][Full Text] [Related]
20. [The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].
Carrada-Bravo T
Rev Alerg Mex; 1994; 41(3):69-76. PubMed ID: 9377108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
